These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8733688

  • 1. Peripheral blood stem cell transplantation in myeloma using CD34 selected cells.
    Johnson RJ, Owen RG, Smith GM, Child JA, Galvin M, Newton LJ, Rawstron A, Major K, Woodhead V, Robinson F, Jack A, Morgan GJ.
    Bone Marrow Transplant; 1996 May; 17(5):723-7. PubMed ID: 8733688
    [Abstract] [Full Text] [Related]

  • 2. A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis.
    Gandhi M, Jestice H, Scott M, Bloxham D, Bass G, Craig J, Marcus R.
    Bone Marrow Transplant; 1999 Aug; 24(4):369-75. PubMed ID: 10467325
    [Abstract] [Full Text] [Related]

  • 3. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.
    Abonour R, Scott KM, Kunkel LA, Robertson MJ, Hromas R, Graves V, Lazaridis EN, Cripe L, Gharpure V, Traycoff CM, Mills B, Srour EF, Cornetta K.
    Bone Marrow Transplant; 1998 Nov; 22(10):957-63. PubMed ID: 9849692
    [Abstract] [Full Text] [Related]

  • 4. High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome.
    Patriarca F, Damiani D, Fanin R, Grimaz S, Geromin A, Cerno M, Sperotto A, Silvestri F, Zaja F, Baccarani M.
    Haematologica; 2000 Mar; 85(3):269-74. PubMed ID: 10702815
    [Abstract] [Full Text] [Related]

  • 5. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M, Winkler J, Waller C, Lange W, Mertelsmann R, Henschler R.
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [Abstract] [Full Text] [Related]

  • 6. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.
    Dyson PG, Horvath N, Joshua D, Barrow L, Van Holst NG, Brown R, Gibson J, To LB.
    Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530
    [Abstract] [Full Text] [Related]

  • 7. Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma.
    Schiller G, Vescio R, Freytes C, Spitzer G, Lee M, Wu CH, Cao J, Lee JC, Lichtenstein A, Lill M, Berenson R, Berenson J.
    Bone Marrow Transplant; 1998 Jan; 21(2):141-5. PubMed ID: 9489630
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J, Brugger W, Bertz H, Behringer D, Kunzmann R, Weber-Nordt RM, Kanz L, Mertelsmann R.
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [Abstract] [Full Text] [Related]

  • 9. Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cells.
    Martinelli G, Terragna C, Lemoli RM, Cavo M, Benni M, Motta MR, Amabile M, Ottaviani E, Testoni N, de Vivo A, Tura S.
    Haematologica; 1999 May; 84(5):397-404. PubMed ID: 10329917
    [Abstract] [Full Text] [Related]

  • 10. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V.
    Natl Med J India; 2003 May; 16(1):16-21. PubMed ID: 12715951
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
    Alici E, Björkstrand B, Treschow A, Aints A, Smith CI, Gahrton G, Dilber MS.
    Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
    [Abstract] [Full Text] [Related]

  • 12. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone, paclitaxel, etoposide, cyclophosphamide (d-TEC) and G-CSF for stem cell mobilisation in multiple myeloma.
    Bilgrami S, Bona RD, Edwards RL, Li Z, Naqvi B, Shaikh A, Furlong F, Fox J, Clive J, Tutschka PJ.
    Bone Marrow Transplant; 2001 Jul; 28(2):137-43. PubMed ID: 11509931
    [Abstract] [Full Text] [Related]

  • 14. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
    Poloucková A, Vodvárková A, Kobylka P, Hrubá A, Gasová Z, Marinov I, Fales I, Sedlácek P, Kozák T, Starý J.
    Neoplasma; 2001 Jul; 48(5):374-81. PubMed ID: 11845982
    [Abstract] [Full Text] [Related]

  • 15. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF, Habsah A, Teh HS, Goh KY, Fadilah SA, Cheong SK.
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [Abstract] [Full Text] [Related]

  • 16. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
    Koç ON, Gerson SL, Phillips GL, Cooper BW, Kutteh L, Van Zant G, Reece DE, Fox RM, Schupp JE, Tainer N, Lazarus HM.
    Bone Marrow Transplant; 1998 Feb; 21(4):337-43. PubMed ID: 9509966
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
    de la Rubia J, Bladé J, Lahuerta JJ, Ribera JM, Martínez R, Alegre A, García-Laraña J, Fernández P, Sureda A, de Arriba F, Carrera D, Besalduch J, García Boyero R, Palomera Bernal L, Hernández MT, García PR, Pérez-Calvo J, Alcalá A, Casado LF, San Miguel J.
    Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
    [Abstract] [Full Text] [Related]

  • 20. Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy.
    Singhal S, Mehta J, Desikan K, Siegel D, Singh J, Munshi N, Spoon D, Anaissie E, Ayers D, Barlogie B.
    Bone Marrow Transplant; 1999 Jul; 24(1):13-7. PubMed ID: 10435728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.